Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ventero M.P.
- Herrero R.
- Tyshkovska I.
- Valverde-Fredet M.-D.
- Rodríguez J.C.
- Rodríguez-Fernández M.
- González-De-La-Aleja P.
- Trigo M.
- Parra M.
- Aller A.-I.
- Otero S.
- Espindola-Gomez R.
- Ramos J.M.
- León E.M.
- García M.
- Navarrete-Lorite M.N.
- Llenas-García J.
- Portillo I.
- Jover F.
- Caston J.J.
- Gil C.
- Vinuesa-Garcia D.
- Gomez-Ayerbe C.
- Martínez Marcos F.J.
- Merchante N.
- De Lucas E.M.
Grupos
Abstract
Alterations in the gut microbiome are central to the pathogenesis and recurrence of Clostridioides difficile infection (CDI). Objective To evaluate intestinal microbiome changes during CDI and their association with recurrence, sex, age, and immunosuppression. Methods Patients from the CDI-ANCRAID-SEICV cohort were consecutively enrolled. Stool samples were obtained at diagnosis (Dx), end of treatment (ET), and eight weeks post-treatment (8W) or upon recurrence. Microbiota composition was analyzed by 16S rRNA sequencing using QIIME2 and R. Outcomes were compared by demographics, immunosuppression, and treatment (vancomycin [VNC], vancomycin-bezlotuzumab [VNC-BZL], fidaxomicin [FDX]). Results Among 143 patients, non-recurrent cases showed higher biodiversity at 8W versus diagnosis (H p = 0.002, ASVs p < 0.001), unlike recurrent cases. Diversity decreased with VNC (H p > 0.001, ASVs p < 0.001) but was preserved with FDX (H p = 0.15). Recovery of Shannon diversity was limited in women (p = 0.50) and immunocompromised patients (p = 0.31). At ET, Fusobacteria and Verrucomicrobiota were less abundant in recurrent than non-recurrent cases (0.77%, 0.53% vs 3.43%, 3.50%). FDX-treated samples showed higher Bacteroidetes (31.33%) compared to VNC (5.23%) or VNC-BZL (3.12%). Women exhibited increased Firmicutes abundance (p = 0.034). Conclusions Restoration of microbial diversity correlates with CDI resolution. FDX preserves gut microbiota better than VNC or VNC-BZL. Women and immunocompromised patients demonstrate impaired microbiota recovery. © 2026 Ventero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Datos de la publicación
- ISSN/ISSNe:
- 1553-7366, 1553-7374
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 41941490
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 2,596 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
PLoS Pathogens PUBLIC LIBRARY SCIENCE
Citas Recibidas en Web of Science: 1
Citas Recibidas en Scopus: 1
Documentos
- No hay documentos
Filiaciones
Keywords
- Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Gastrointestinal Microbiome; Humans; Immunosuppression Therapy; Male; Middle Aged; Recurrence; RNA, Ribosomal, 16S; Sex Factors; Vancomycin; fidaxomicin; vancomycin; antiinfective agent; RNA 16S; vancomycin; adult; aged; Article; Bacillota; Bacteroidetes; Charlson Comorbidity Index; chronic respiratory tract disease; Clostridium difficile infection; cohort analysis; colitis; comorbidity; controlled study; diabetes mellitus; dynamics; female; Fusobacteria; gut microbiome; high throughput sequencing; hospitalization; human; immunosuppressive treatment; major clinical study; male; microflora; middle aged; nonhuman; polymerase chain reaction; recurrent disease; RNA sequencing; sample; sex; Shannon index; solid tumor; stool sample; Clostridioides difficile; Clostridium infection; drug effect; drug therapy; feces; genetics; immunology; immunosuppressive treatment; intestine
Cita
Ventero MP,Herrero R,Tyshkovska I,Valverde M-D,Rodríguez JC,Rodríguez M,González P,Trigo M,Parra M,Aller A-I,Otero S,Espindola R,Ramos JM,León EM,García M,Navarrete MN,Llenas J,Portillo I,Jover F,TASIAS M,Caston JJ,Gil C,Vinuesa D,Gomez C,Martínez FJ,Merchante N,De Lucas EM. Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression. PLoS Pathog. 2026. 22. e1014063. IF:4,900. (1).
Portal de investigación